30
Oct
2025
Novartis Acquires Avidity for $12B, Novo Stiff-Arms Pfizer & Intellia Woes
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
30
Oct
2025
The Outsized Significance of A New Study of AI in Diabetes Prevention
A lifestyle intervention delivered by AI was found to be as effective as validated traditional interventions delivered by trained experts in a carefully conducted implementation study conducted by Johns Hopkins researchers and just published in JAMA. These results have broad significance and speak to the promise of AI to deliver promising behavior-change interventions at unprecedented scale. Context: The DPP The... Read More